Malvinder Mohan Singh

Sebi directs Singh brothers, 8 other entities to repay over Rs 403 cr with interest to Fortis Healthcare

In a 21-page interim order, Sebi said that prima facie the role of FHL and Fortis Hospitals Ltd (FHsL) in the alleged diversion of funds through conduit entities has been established.

Shivinder Singh withdraws petition against brother Malvinder: All you need to know about the Singh brothers fracas

NCLT granted Shivinder Mohan Singh's request to withdraw the petition of oppression and mismanagement he had filed against his brother Malvinder

Fortis Healthcare: Shivinder Mohan Singh to withdraw NCLT petition against brother Malvinder after mother intervenes

Shivinder Singh had filed a lawsuit in the NCLT against brother Malvinder saying alleging "oppression and mismanagement" at their joint businesses.

Fortis spat: Shivinder Singh says filing lawsuit against Malvinder, Sunil Godhwani was 'long overdue'; full text of letter

The spat between the Singh brothers -- Malvinder, Shivinder, who are also co-promoters of the beleagured Fortis Health Care has come out in the open

Yes Bank sells 2.17% stake in Fortis Healthcare; had acquired 17% in firm last month

Yes Bank had acquired 17.31 percent stake in Fortis Healthcare following invocation of nearly 9 crore pledged shares last month

Yes Bank acquires 17.31% stake in Fortis Healthcare following invocation of nearly 9 crore pledged shares

Yes Bank has acquired 17.31 percent stake in Fortis Healthcare following invocation of nearly 9 crore pledged shares last month

Fortis Healthcare seeks 15-day extension to declare Q2, Q3 results

Fortis Healthcare, India's second-largest hospital chain, has sought a 15-day extension to declare earnings for the second and third quarter of the current financial year citing statutory auditors' inability to complete the audit before the stipulated board meeting

Fortis Healthcare shares soar 24.5% to Rs 157.05 on merger buzz

Shares of Fortis Healthcare jumped 24.5 percent on Friday amid reports that Manipal hospital, backed by TPG, is in advanced talks to merge the company with itself.

Fortis vs Daiichi Sankyo: Singh brothers resign after Delhi HC upholds Rs 3,500 cr arbitral award to Japanese pharma

A tribunal in Singapore had passed the verdict in favour of Daiichi holding that the former Ranbaxy promoters had concealed certain information

Former Ranbaxy promoters count on disclosure to counter Daiichi claims

Facing arbitration claims here by Daiichi Sankyo, Ranbaxy's former Indian promoters are counting on 'representations and warranties' made in the share purchase agreement signed with the Indian drugmaker's current Japanese owners in 2008.